open image in gallery Semaglutide - the active ingredient in Ozempic and other Novo products - has been linked to eye conditions (Getty/iStock) In subgroup analyses, the elevated risk for NAION ...

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide -- the active ingredient in Ozempic ... The higher risk of developing the sight-threatening eye problem ...

Regular monitoring of your health will allow your doctor to keep an eye on whether Ozempic ... to reduce the risk of cardiovascular events and to manage chronic kidney disease in people with ...

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication ...

It’s hard to keep up with all of the potential perks of going on a GLP-1 receptor agonist medication like Ozempic ... may help reduce the risk of cardiovascular disease and colorectal cancer ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition. The findings about ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition ... the active ingredient in ...